Paper. Korthuis PT, Cook RR, Gregoire D et al.. JAMA Network Open, 3 Aug 2026.
Tags: Human, Psilocybin, Depression, PTSD, Anxiety.
346 clients at 24 licensed service centers were followed for three months. Four people (1.2%, all first-time users) had reactions that needed medical attention. At one month, 92% said they had benefited. At three months, the share with moderate-to-severe depression was 60% lower than at the start, with similar drops for anxiety and PTSD symptoms.
How much weight it carries: No control group. The sample was mostly white, college-educated and well-off, so it may not reflect who would use these services more widely. (Humans, n = 346, No control group, Peer reviewed)